Juvena Therapeutics
CA - Redwood CityBiotechnology
Focus: Juvena Therapeutics is a Series A biotech focused on tissue regeneration and repair for muscle and metabolic diseases. The company is pre-revenue with an early-stage pipeline and minimal public visibility.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
SERIES A
Open Jobs
0
About Juvena Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Juvena Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
JUV-161, Placebo
Healthy VolunteerClinical Trials (1)
NCT06918925First-In-Human Study to Evaluate Single and Multiple Ascending Doses of JUV-161 in Healthy Adult Volunteers
Phase 1Help build intelligence for Juvena Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.